No arrhythmias triggered in heart failure patients upon caffeine intake
20-10-2016 • Zuchinali P, et al, JAMA, 2016
The acute ingestion of high doses of caffeine in 51 HF patients did not induce arrhythmias neither at rest, nor during exercise.
News • 19-10-2016
AHA Scientific Statement gives guidance on how to limit drug-drug-interactions with statins
Clinically significant drug-drug-interactions with statins and other medications given to treat CVD may be prevented. This document gives recommendations on how to minimise adverse effects.
News • 17-10-2016
AHA panel gives in-depth evaluation of link between hypertension and dementia
The panel considers the evidence insufficient to formulate evidence-based recommendations, but personalised BP management is probably the wisest approach to safeguard cerebrovascular health.
Lower mortality rate with 25 years of intensive lipid-lowering therapy of CAD
10-10-2016 • Zhao XQ et al., J Clin Lipidol 2016
Intensive lipid-lowering therapy for 25 years was associated with significant reductions in CV and total mortality in men with increased LDL-C levels and established coronary artery disease.
News • 28-9-2016
Better sleep for better cardiometabolic health
AHA issued a Scientific Statement in which they review evidence on the relation between too short and too long sleep duration and CV risk, and call for more awareness in clinical practice.
CV incidence decreased with tea consumption
26-9-2016 • Miller PE, et al, Am J Med, 2016
Both prevalence and progression of coronary artery calcium and number of CV events were decreased when drinking more than one cup of tea a day.
News • 20-10-2016
EPCCS Practical Guidance on Heart Failure Diagnosis and Management in Primary Care
Based on the Heart Failure session and discussion during the 8th EPCCS Annual Meeting in Prague, this guidance document was written to help physicians diagnose and manage heart failure in their primary care practice.
CV morbidity and mortality enhanced with higher pulse pressure
18-10-2016 • McEvoy JW, et al, JACC, 2016
Particularly when DBP was <60 mmHg and SBP above 120 mmHg, patients had higher troponin levels, more frequent CHD events and mortality.
DOACs also beneficial for elderly AF and VTE patients
11-10-2016 • Sadlon AH, Swiss Med Wkly, 2016
Rivaroxaban, apixaban, dabigatran and edoxaban were superior to VKAs in a meta-analysis of 8 studies comprising elderly patients with atrial fibrillation or venous thromboembolism.
Recurrent risk varies substantially in vascular patients: risk stratification can be improved
10-10-2016 • Kaasenbrood L, et al., Circulation 2016
There is substantial variation in the estimated 10-year risk of recurrent vascular events in patients with vascular disease that supports the need for optimisation of risk stratification of these patients.
Patients at very high CV risk would benefit from stricter monitoring and adherence to guidelines
26-9-2016 • Heintjes E, et al., Curr res med opin 2016
Despite lipid-lowering therapy, a large proportion of patients with CV events and/or T2DM did not meet the less stringent Dutch LDL-c target (2.5 mmol/L), BP and HbA1c targets.
Metabolic factors may identify individuals prone to develop statin-related diabetes
19-9-2016 • Kohli P et al., Am J Cardiol 2016
The diabetogenic impact of statin treatment is relatively modest, but is aggravated if plasma glucose, TG concentrations and BMI increase.
EPCCS 9th Annual Scientific Meeting
March 30-31, 2017, Dublin, Ireland
All upcoming meetings...
Meeting reports & resources
EPCCS Guidance Documents
Evidence- and meeting-based guidance for primary care
Report of 8th Annual EPCCS meeting held in Prague.
Report of 7th Annual EPCCS meeting held in Brussels.
Report of 6th Annual EPCCS meeting held in London
All meeting reports...